IPO - Aura Biosciences, Inc.

Form Type: 8-K

Filing Date: 2025-05-16

Corporate Action: Ipo

Type: New

Accession Number: 000119312525121677

Filing Summary: On May 15, 2025, Aura Biosciences, Inc. entered into an underwriting agreement with Leerink Partners LLC for an underwritten public offering of 11,735,565 shares of common stock and pre-funded warrants totaling 3,571,435 shares, alongside common stock warrants for 3,826,750 shares. The offering price for the common stock was set at $4.90 each, while the pre-funded warrants were priced at $4.89999 each. The offering closed on May 16, 2025, yielding net proceeds of roughly $69.9 million, which will fund clinical programs and general corporate purposes until the first half of 2027. The offering was underpinned by a previously filed Registration Statement and included customary representations and warranties from both parties. Additionally, the company updated its corporate presentation for investor meetings on the closing date, and filed related documents as exhibits within the report.